石四药集团(02005)：硫酸镁注射液及氢溴酸伏硫西汀片取得药品生产注册批件
石四药集团(02005)发布公告，集团已取得中国国家药品监督管理局有关硫酸镁注射液(20ml：10g，10ml：5g 及 2ml：1g)及氢溴酸伏硫西汀片(10mg)的药品生产注册批件，分别属于化学药品第3类及第4类，视同通过一致性评价。
硫酸镁注射液作为抗惊厥药，主要用于妊娠高血压，以降低血压，治疗先兆子痫和子痫。氢溴酸伏硫西汀片主要用于治疗成人抑郁症。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.